Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma

In conclusion, p.Q787Q is neither a suitable prognostic nor predictive biomarker for ADC patients receiving anti‐EGFR therapy in first or second line of therapy. This article is protected by copyright. All rights reserved.

Source: Genes, Chromosomes and Cancer - October 16, 2016 Category: Cancer & Oncology Authors: Jonas Leichsenring, Anna ‐Lena Volckmar, Nikolaus Magios, Cristiano Manuel Morais de Oliveira, Roland Penzel, Regine Brandt, Martina Kirchner, Farastuk Bozorgmehr, Michael Thomas, Peter Schirmacher, Arne Warth, Volker Endris, Albrecht Stenzinger Tags: Research Article Source Type: research